Developed by Merck, the new cholesterol pill, can lower LDL levels by around 605 in adults with a genetic form of high ...

A new daily pill reduced bad cholesterol by 60% in a groundbreaking study of 303 adults with a genetic condition, offering ...

Discover Enlicitide, a new daily pill for genetic high cholesterol (HeFH). A recent trial shows it lowers bad LDL cholesterol by over 55%. Is this the future of HeFH treatment?

Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...

Enlicitide is an investigational oral PCSK9 inhibitor that has shown substantial reductions in LDL-C levels in patients with ...

Key points A 56-year-old woman presented to the emergency department with a 2-day history of central chest pain and dyspnea. Her medical history included having had a myocardial infarction (MI) with n ...

A new pill developed by Merck is showing promise in helping people with a genetic condition called heterozygous familial hypercholesterolemia (HeFH). This condition causes very high levels of LDL ...

A woman on clozapine develops severe gastrointestinal hypomotility that progresses to toxic megacolon and multiorgan failure, ...

Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 Bio Phase 2 basket trial ...

Erika Prouty, PharmD, is a professional community pharmacist that specializes in blood cholesterol readings, blood pressure readings, and medication therapy management. Vitamin D helps your body ...

MANY FACTORS CAN CAUSE your cholesterol levels to creep up, including your diet and how much you exercise. So sometimes making lifestyle changes can lower your numbers. Cholesterol is a fat-like ...

Reflecting persistent drug quality concerns in India's pharmaceutical market, the Central Drugs Standard Control Organisation ...